单中心多因素回顾性研究:利用[68Ga]Ga-PSMA-11全身PET/CT提高原发性前列腺癌诊断准确性
该单中心回顾性研究纳入84例治疗前接受[68Ga]Ga-PSMA-11全身PET/CT的疑似原发性前列腺癌患者,分析PSA及多项影像参数。多因素回归显示前列腺SUVmax是独立预测因子,界值11.5,比值比1.221,用于提高诊断准确性。
要点
- 前列腺SUVmax是[68Ga]Ga-PSMA-11全身PET/CT诊断原发性前列腺癌的独立预测因子,界值11.5,比值比1.221。
- 前列腺SUVmax预测前列腺癌的曲线下面积为0.864(95%CI 0.757-0.972)。
- PSA水平预测前列腺癌的曲线下面积为0.620(95%CI 0.485-0.755),低于前列腺SUVmax。
核心结论
- 前列腺SUVmax以11.5为界值是提高[68Ga]Ga-PSMA-11全身PET/CT对前列腺癌诊断准确性的独立预测因子。
研究设计与样本
- 单中心回顾性研究,纳入84例治疗前接受[68Ga]Ga-PSMA-11全身PET/CT的疑似原发性前列腺癌患者。
主要发现
- 前列腺癌组与非前列腺癌组在年龄、身高、体重、注射剂量上无显著差异,而PSA水平、前列腺SUVmax、TLP、MTV、CAP存在显著差异。
- 由前列腺SUVmax衍生的SUVmax-PSMA-T/L和SUVmax-PSMA-T/M均有显著差异。
- PSA、前列腺SUVmax、SUVmax-PSMA-T/L、SUVmax-PSMA-T/M、TLP、MTV、CAP预测前列腺癌的曲线下面积分别为0.620(95%CI 0.485-0.755)、0.864(95%CI 0.757-0.972)、0.819(95%CI 0.704-0.935)、0.876(95%CI 0.771-0.980)、0.845(95%CI 0.741-0.949)、0.820(95%CI 0.702-0.938)、0.627(95%CI 0.499-0.754)。
- 多因素回归分析显示前列腺SUVmax为独立预测因子,界值11.5,比值比1.221。
关键数值与推荐
- 前列腺SUVmax预测前列腺癌的界值为11.5,比值比1.221。
- 前列腺SUVmax预测前列腺癌的曲线下面积为0.864(95%CI 0.757-0.972)。
- PSA水平预测前列腺癌的曲线下面积为0.620(95%CI 0.485-0.755)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To improve the diagnostic accuracy of initial detection in patients with suspected primary prostate cancer (PCa). METHODS: Eighty-four patients who underwent Gallium-68-labeled prostate-specific membrane antigen ([68Ga]Ga-PSMA-11) total-body positron emission tomography/computed tomography (PET/CT) imaging before treatment in our department were enrolled. The maximum standard uptake value (SUVmax) of the prostate (SUVmax-PSMA), liver (SUVmax-PSMA-L), and mediastinal blood pool (SUVmax-PSMA-M) was measured using [68Ga]Ga-PSMA-11 total-body PET/CT imaging. The [68Ga]Ga-PSMA-11 derived metabolic tumor volume (MTV), the total lesion (TLP), and the cross-sectional areas of focal concentration in the prostate (CAP) were also determined. Besides, the prostate-specific antigen (PSA) levels and the above imaging characteristics were analyzed using receiver operating characteristic curves to identify the cutoff value to improve the diagnostic accuracy of suspected PCa. Finally, a multivariate regression analysis was conducted to discover the independent predictor to improve the diagnostic accuracy on [68Ga]Ga-PSMA-11 total-body imaging. RESULTS: There was no significant difference between the PCa and Non-PCa groups in age, height, weight, injected dose, except for the PSA levels, the SUVmax-PSMA, TLP, MTV, and CAP. Besides, the SUVmax-PSMA-T/L and SUVmax-PSMA-T/M derived from SUVmax-PSMA were both significantly different. In addition, the areas under the curve of PSA levels, SUVmax-PSMA, SUVmax-PSMA-T/L, SUVmax-PSMA-T/M, TLP, MTV, and CAP to predict PCa on [68Ga]Ga-PSMA-11 imaging were 0.620 (95% confidence interval (CI) 0.485-0.755), 0.864 (95% CI 0.757-0.972), 0.819 (95% CI 0.704-0.935), 0.876 (95% CI 0.771-0.980), 0.845 (95% CI 0.741-0.949), 0.820 (95% CI 0.702-0.938), 0.627 (95% CI 0.499-0.754), respectively. However, a multivariate regression analysis showed that SUVmax-PSMA was an independent predictor, with a cutoff value of 11.5 and an odds ratio of 1.221. CONCLUSION: The SUVmax-PSMA with a cutoff value of 11.5 was an independent predictor to improve the diagnostic accuracy of PCa on [68Ga]Ga-PSMA-11 total-body imaging.
引用
- Lv J, Yu H, Yin H, et al. A single-center, multi-factor, retrospective study to improve the diagnostic accuracy of primary prostate cancer using [68Ga]Ga-PSMA-11 total-body PET/CT imaging. Eur J Nucl Med Mol Imaging. 2023. PMID: 37940684. doi:10.1007/s00259-023-06464-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。